Low-mass-ion discriminant equation (LOME) for ovarian cancer screening
- Authors
- Lee, Jun Hwa; Yoo, Byong Chul; Kim, Yun Hwan; Ahn, Sun-A; Yeo, Seung-Gu; Cho, Jae Youl; Kim, Kyung-Hee; Kim, Seung Cheol
- Issue Date
- 12-Oct-2016
- Publisher
- BioMed Central
- Keywords
- Ovarian cancer; Screening; Serum profiling; MALDI-TOF mass spectrometry; Pattern recognition
- Citation
- BioData Mining, v.9
- Journal Title
- BioData Mining
- Volume
- 9
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8678
- DOI
- 10.1186/s13040-016-0111-7
- ISSN
- 1756-0381
- Abstract
- Background: A low-mass-ion discriminant equation (LOME) was constructed to investigate whether systematic low-mass-ion (LMI) profiling could be applied to ovarian cancer (OVC) screening. Results: Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry was performed to obtain mass spectral data on metabolites detected as LMIs up to a mass-to-charge ratio (m/z) of 2500 for 1184 serum samples collected from healthy individuals and patients with OVC, other types of cancer, or several types of benign tumor. Principal component analysis-based discriminant analysis and two search algorithms were employed to identify discriminative low-mass ions for distinguishing OVC from non-OVC cases. OVC LOME with 13 discriminative LMIs produced excellent classification results in a validation set (sensitivity, 93. 10 %; specificity, 100.0 %). Among 13 LMIs showing differential mass intensities in OVC, 3 metabolic compounds were identified and semi-quantitated. The relative amount of LPC 16: 0 was somewhat decreased in OVC, but not significantly so. In contrast, (D,L)-glutamine and fibrinogen alpha chain fragment were significantly increased in OVC compared to the control group (p = 0.001 and 0.002, respectively). Conclusion: The present study suggested that OVC LOME might be a useful non-invasive tool with high sensitivity and specificity for OVC screening. The LOME approach could enable screening for multiple diseases, including various types of cancer, based on a single blood sample. Furthermore, the serum levels of three metabolic compounds-(D,L)-glutamine, LPC 16: 0 and fibrinogen alpha chain fragment-might facilitate screening for OVC.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Radiation Oncology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8678)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.